PRKAA1 and neoplasm: To counteract the hypoxic tumor microenvironment, potential approaches include using gene therapy to knock down AMPKα1 in tumor cells or pretreating T cells with AMPK kinase activators, developing CAR-T cells with low oxygen requirements.